NeuroVanda Therapeutics

NeuroVanda Therapeutics is a pioneering biotechnology research company dedicated to developing transformational therapies for neurodegenerative diseases. Based in Singapore, NeuroVanda Therapeutics leverages deep insights into disease mechanisms, employing disease-relevant models to pair the best-suited therapeutic modalities with the most pertinent targets. With a focus on innovation and impactful solutions, NeuroVanda Therapeutics is committed to advancing the field of neurodegenerative disease treatment.

NeuroVanda Therapeutics utilizes translational models developed over decades in collaboration with world-renowned scientific founders from prestigious institutions such as the University of Pennsylvania, Weill Cornell Medicine, and the University of California, San Francisco. This collaborative approach ensures that NeuroVanda Therapeutics remains at the forefront of cutting-edge research and development in the biotechnology sector. The primary address of NeuroVanda Therapeutics is 1 N Buona Vista Link, Singapore, 139691, SG.

The experienced drug hunters at NeuroVanda Therapeutics possess deep expertise in developing novel modalities such as protein degraders to tackle the most pertinent of targets. NeuroVanda Therapeutics is poised to make significant contributions to the biotechnology landscape. We invite the manager of NeuroVanda Therapeutics to create a customized and exclusive company showcase and product listing on our platform, and provide information that will be completed soon with the support of the company’s management.